Cargando…

Multiple Sclerosis in Parsis: A Historical Issue

Detalles Bibliográficos
Autor principal:	NASER MOGHADASI, Abdorreza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2014
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419182/ https://www.ncbi.nlm.nih.gov/pubmed/25988104

Ejemplares similares

Agnosia in Canon: a Historical Issue
por: NASER MOGHADASI, Abdorreza
Publicado: (2014)

Neuroplasticity in Early Onset Multiple Sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2014)

Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients
por: Moghadasi, Abdorreza Naser
Publicado: (2021)

Can multiple sclerosis as a cognitive disorder influence patients’ dreams?
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2013)

Bacterial meningitis in a patient with multiple sclerosis receiving Tysabri
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2016)

Is Monkeypox a Concern in Multiple Sclerosis Patients? A Letter to Editor
por: Asadollahzadeh, Elnaz, et al.
Publicado: (2022)

Is anemia a probable cause of fatigue in patients with multiple sclerosis?
por: Mir-Reza, Soha, et al.
Publicado: (2013)

Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”
por: Asadollahzade, Elnaz, et al.
Publicado: (2022)

Comment on “The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging”
por: Asadollahzade, Elnaz, et al.
Publicado: (2022)

Acute attack in a patient with multiple sclerosis 2 days after COVID vaccination: a case report
por: Seyed Ahadi, Maral, et al.
Publicado: (2021)

The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis: Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19?
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

Ability to gain religious experiences as a part of cognitive abilities
por: Naser Moghadasi, Abdorreza
Publicado: (2014)

First Skull Surgery in Iran: The Burned City and a 4800-Year-Old Skull
por: NASER MOGHADASI, Abdorreza
Publicado: (2014)

Artificial Eye in Burnt City and Theoretical Understanding of How Vision Works
por: MOGHADASI, Abdorreza Naser
Publicado: (2014)

Tragedy of Rostam and Sohrab: First Example Introducing the Science of Mytho-Pathology
por: NASER MOGHADASI, Abdorreza
Publicado: (2014)

The Burnt City and the Evolution of the Concept of “Probability” In the Human Brain
por: NASER MOGHADASI, Abdorreza
Publicado: (2015)

First Visual Evidence of Leprosy in the Continental Shelf of Iran
por: NASER MOGHADASI, Abdorreza
Publicado: (2015)

The first attack of multiple sclerosis presented immediately after voluntary and intensive weight loss: A case series
por: Bitarafan, Sama, et al.
Publicado: (2017)

Encephalopathy associated with COVID-19 in a patient with multiple sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2021)

Eculizumab in the treatment of neuromyelitis optica spectrum disorder
por: Nabizadeh, Fardin, et al.
Publicado: (2023)

The big challenge for neurologists in treating patients with multiple sclerosis in the post-COVID-19 era
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

Anti-N-methyl-D-aspartate receptor optic neuritis in a patient without history of encephalopathy
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2019)

A Smartphone-based Application for Self-Management in Multiple Sclerosis
por: Mokhberdezfuli, Mahdieh, et al.
Publicado: (2021)

Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Age-related serum vitamin B12 concentrations in epileptic patients receiving valproate monotherapy
por: Motamedi, Mahmood, et al.
Publicado: (2013)

Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed
por: Naser Moghadasi, Abdorreza
Publicado: (2021)

Validation of the Persian version of dysphagia in multiple sclerosis questionnaire for the assessment of dysphagia in multiple sclerosis
por: Jafari, Zahra, et al.
Publicado: (2018)

Intractable headache with autonomic features after gamma knife radiosurgery: A case report
por: Togha, Mansoureh, et al.
Publicado: (2019)

Initial clinical presentation of multiple sclerosis with concurrent COVID-19 infection: Case report and literature review
por: Ebadi, Zahra, et al.
Publicado: (2022)

Clinical Evaluation of 38 Patients with Juvenile Myoclonic Epilepsy
por: NASER MOGHADASI, Abdorreza, et al.
Publicado: (2014)

Association of Limb-Girdle muscular dystrophy with multiple sclerosis: A case report
por: Arzani, Mahsa, et al.
Publicado: (2018)

The co-occurrence of multiple sclerosis and Evans syndrome: A case report
por: Salehizadeh, Saeideh, et al.
Publicado: (2020)

Beta-thalassemia intermedia with ischemic transients misdiagnosed as multiple sclerosis: A case report
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients
por: Haji Akhoundi, Fahimeh, et al.
Publicado: (2020)

Economic sanctions against Iran as an important factor in threatening the health of patients with multiple sclerosis
por: Sahraian, Mohammad Ali, et al.
Publicado: (2021)

Multiple sclerosis and human leukocyte antigen genotypes: Focus on the Middle East and North Africa region
por: Maghbooli, Zhila, et al.
Publicado: (2020)

Attitudes toward vaccination in patients with multiple sclerosis: A report from Iran
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

The study of COVID-19 infection following vaccination in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
por: Rezaeimanesh, Nasim, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lpnlc4prdbr8itu438j479tbj5